Compare Mutual Funds

Pros

-

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

-

INDMoney rank
-
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

4 Years 3 Months

13 Years 3 Months

Fund AUM

₹224 Cr

₹8265 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.47%

0.92%

Exit Load

0.5%

1%

Benchmark Index

Nifty Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

41

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(12.73%)
  2. Divi's Laboratories Ltd(8.75%)
  3. Apollo Hospitals Enterprise Ltd(6.12%)
  4. Max Healthcare Institute Ltd Ordinary Shares(6.08%)
  5. Torrent Pharmaceuticals Ltd(4.26%)
  1. Sun Pharmaceuticals Industries Ltd(13.02%)
  2. Lupin Ltd(7.36%)
  3. Divi's Laboratories Ltd(6.58%)
  4. Cipla Ltd(6.39%)
  5. Dr Reddy's Laboratories Ltd(6.02%)
No of Sectors

4

1

Top 3 Sectors
  1. Health(95.52%)
  2. Basic Materials(2.18%)
  3. Financial Services(1.3%)

Health

(100%)

Equity %

97.28%

97.37%

Debt %

-

-

P/E

42

34.75

P/B

5.73

5.37

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-7.02%

-4.25%

3-Month Return

-9.05%

-3.24%

6-Month Return

-6.89%

-1.12%

1-Year Return

-7.99%

0.6%

3-Year Return

19.69%

23.12%

5-Year Return

-

15%

Sharpe

0.77

0.97

Alpha

-1.29

0.33

Beta

0.92

0.9

Standard Deviation

16.22

15.32

Information Ratio

-0.57

-0.32

Description

ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhimant Shah, Rohan Korde

Sailesh Raj Bhan, Lokesh Maru, Kinjal Desai, Divya Sharma

Most Popular Comparisons